Over-expression of this cannabinoid receptor has been detected in several types of human cancers, often as heteromers with other GPR (see below), and has been implicated in both cancer progression as well as in cancer inhibition depending upon the type of the cancer, nature of the heteromer as well as cellular context (58). This evidence concerns the gene ALDH18A1 and cancer.